BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1510813)

  • 1. VDJ recombination.
    Alt FW; Oltz EM; Young F; Gorman J; Taccioli G; Chen J
    Immunol Today; 1992 Aug; 13(8):306-14. PubMed ID: 1510813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
    Nacht M; Jacks T
    Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of antigen receptor gene assembly in lymphocytes.
    Oltz EM
    Immunol Res; 2001; 23(2-3):121-33. PubMed ID: 11444378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrearrangements as biomarkers for risk of lymphoid malignancy.
    Kirsch IR; Lista F
    Cancer Surv; 1996; 28():311-27. PubMed ID: 8977043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of V(D)J recombination in double-strand break repair mutants.
    Taccioli GE; Rathbun G; Oltz E; Stamato T; Jeggo PA; Alt FW
    Science; 1993 Apr; 260(5105):207-10. PubMed ID: 8469973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinase deficiency in mouse and man.
    Schwarz K; Hansen-Hagge TE; Bartram CR
    Immunodeficiency; 1993; 4(1-4):249-52. PubMed ID: 8167711
    [No Abstract]   [Full Text] [Related]  

  • 8. Coding joint formation of endogenous T cell receptor genes in lymphoid cells from scid mice: unusual P-nucleotide additions in VJ-coding joints.
    Schuler W; Ruetsch NR; Amsler M; Bosma MJ
    Eur J Immunol; 1991 Mar; 21(3):589-96. PubMed ID: 1849083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessibility and the developmental regulation of V(D)J recombination.
    Schlissel MS; Stanhope-Baker P
    Semin Immunol; 1997 Jun; 9(3):161-70. PubMed ID: 9200327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective V-to-J recombination of T cell receptor gamma chain genes in scid mice.
    Schuler W; Schuler A; Bosma MJ
    Eur J Immunol; 1990 Mar; 20(3):545-50. PubMed ID: 2156708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro.
    Stanhope-Baker P; Hudson KM; Shaffer AL; Constantinescu A; Schlissel MS
    Cell; 1996 Jun; 85(6):887-97. PubMed ID: 8681383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The origins of V(D)J recombination.
    Lewis SM; Wu GE
    Cell; 1997 Jan; 88(2):159-62. PubMed ID: 9008155
    [No Abstract]   [Full Text] [Related]  

  • 13. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
    Swanson PC
    Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The V(D)J recombination activating gene, RAG-1.
    Schatz DG; Oettinger MA; Baltimore D
    Cell; 1989 Dec; 59(6):1035-48. PubMed ID: 2598259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into V(D)J recombination and its role in the evolution of the immune system.
    Thompson CB
    Immunity; 1995 Nov; 3(5):531-9. PubMed ID: 7584143
    [No Abstract]   [Full Text] [Related]  

  • 16. V(D)J recombination and transposition: closer than expected.
    Craig NL
    Science; 1996 Mar; 271(5255):1512. PubMed ID: 8599105
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA topology and V(D)J recombination: a tentative connection.
    Tatu CA; Drugărin D; Stănescu DI; Păunescu V
    Roum Arch Microbiol Immunol; 1993; 52(4):255-60. PubMed ID: 7827362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion.
    Breit TM; Verschuren MC; Wolvers-Tettero IL; Van Gastel-Mol EJ; Hählen K; van Dongen JJ
    J Immunol; 1997 Nov; 159(9):4341-9. PubMed ID: 9379030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restraining the V(D)J recombinase.
    Roth DB
    Nat Rev Immunol; 2003 Aug; 3(8):656-66. PubMed ID: 12974480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.